Smoking and the periodontium: reduced bleeding conceals disease rather than indicating its absence

Smoking is the most important modifiable risk factor for periodontitis, and it produces an effect that makes the disease harder to recognise precisely in those most affected.

Nicotine acts as a vasoconstrictor on the gingival capillaries. The consequence is that a smoker with advanced periodontitis may show less bleeding on probing than a non-smoker with milder disease.

The resulting error is concrete: the clinical sign relied upon to assess inflammation is blunted exactly where destruction is greatest.

In smokers, therefore, more weight is given to probing depth, attachment loss and the radiographic picture, and less to absence of bleeding, which offers no reassurance.

The appearance of the gingiva is itself deceptive: it looks paler and more fibrotic, with margins that seem healthy while concealing deep pockets.

The effect on healing after therapy is documented and substantial. Pocket reduction after instrumentation is smaller, and the response to periodontal and regenerative surgery is poorer.

On implants, smoking increases the risk of peri-implantitis and failure, and this should be communicated before planning rather than after. It forms part of informed consent as much as surgical risks do.

Heated tobacco devices and electronic cigarettes are not equivalent to quitting. The nicotine remains, and with it the vasoconstriction and its effects on the tissues.

The evidence on the oral effects of these devices is still developing, and the prudent message is that they represent a change of exposure rather than its elimination.

The useful message in practice is that quitting produces measurable improvement. The response to periodontal therapy in those who have stopped progressively approaches that of non-smokers.

Framing this as a concrete and near-term gain works better than a generic warning: a patient told the next appointment will yield better results is more receptive than one addressed about risks twenty years hence.

Staining and halitosis are why the smoking patient presents, and they are an opportunity. It is the moment when the subject can be raised without sounding like an unsolicited lecture.

In summary: reduced bleeding in smokers conceals disease, assessment shifts to probing and radiographs, implant risk must be stated before planning, and quitting improves the response to therapy within a timeframe worth communicating.